Consultant at the Pediatric Hematology/Oncology
IRCCS Policlinico San Matteo, Pavia, Italy
Dr. Comoli received her medical degree from the University of Pavia, Italy, and completed her residency training in Pediatrics at the Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, discussing a thesis in Pediatric Hematology/Oncology. In 1996-97, Dr. Comoli was a visiting fellow at the Department of Virology and Molecular Biology, and Department of Hematology, St. Jude Childrens’ Research Hospital, Memphis, USA, attending the Cell and Gene Therapy Program. Upon her return to Italy, she served as a consultant at the Pediatric Haematology/Oncology and Hematopoietic Stem Cell Transplant Unit, Policlinico San Matteo, Pavia, where she was appointed coordinator of the Antiviral T-cell Therapy Program. Her research group pioneered Epstein-Barr virus-targeted cell therapy for the treatment of posttransplant lymphoproliferative disease occurring in solid organ transplantation, and of nasopharyngeal carcinoma. She is a recipient of the “Gennaro e Raffaele Sansone” Award by the Italian Association of Paediatric Haematology and Oncology (AIEOP), and of the “van Bekkum Award” by the European Group for Blood and Marrow Transplantation (EBMT). Dr. Comoli is a member of AIEOP, EBMT and the International Society of Cell Therapy, and was Faculty Member in Courses organized by the European School of Hematology and the European Renal Association, and in Master Courses in Pediatric Hematology organized by the University “La Sapienza”, Roma, and in Pediatric Immunology organized by the University of Pavia. She has authored multiple peer-reviewed articles, and has served on the editorial board of the journals Transplantation and Cytotherapy. She is the recipient of funding from the Italian Ministry of Health, the Regional Health Council, and the Italian Cancer Association. Since 2016, she is the Director of the GMP Laboratory Cell Factory, Fondazione IRCCS Policlinico San Matteo, Pavia. Her current research interests include applications of cell therapy in transplantation and hematology/oncology, and transplant immunology.